APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Drug

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Drug Market Outlook and Growth Opportunities 2026

28 December 2025208 pages

Choose your research edition.

Industry ResearchVeterinary Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Drug Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.

This report provides an overview of the global Veterinary Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Veterinary Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Drug Segment by Company

Zoetis

Elanco

Boehringer Ingelheim

Merck

Virbac

Ceva

Vetoquinol

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

Veterinary Drug Segment by Type

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Veterinary Drug Segment by Application

Pets

Cattle

Poultry

Swine

Others

Veterinary Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Drug industry.

Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Drug Industry Trends Table 2. Veterinary Drug Industry Drivers Table 3. Veterinary Drug Industry Opportunities and Challenges Table 4. Veterinary Drug Industry Restraints Table 5. Global Veterinary Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Drug Revenue Share by Company (2021-2026) Table 7. Global Veterinary Drug Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Veterinary Drug Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Drug Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Veterinary Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Drug Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Drug Company, Product Type & Application Table 13. Global Veterinary Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Anti-Infectives Table 18. Significant Companies of Anti-Inflammatory Table 19. Significant Companies of Parasiticides Table 20. Significant Companies of Analgesics Table 21. Significant Companies of Sedatives Table 22. Significant Companies of Others Table 23. Global Veterinary Drug Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Veterinary Drug Sales Volume by Type (2021-2026) & (M Units) Table 25. Global Veterinary Drug Sales Volume by Type (2027-2032) & (M Units) Table 26. Global Veterinary Drug Sales Volume Share by Type (2021-2026) Table 27. Global Veterinary Drug Sales Volume Share by Type (2027-2032) Table 28. Global Veterinary Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Veterinary Drug Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Veterinary Drug Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Veterinary Drug Sales Value Share by Type (2021-2026) Table 32. Global Veterinary Drug Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Pets Table 34. Significant Companies of Cattle Table 35. Significant Companies of Poultry Table 36. Significant Companies of Swine Table 37. Significant Companies of Others Table 38. Global Veterinary Drug Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 39. Global Veterinary Drug Sales Volume by Application (2021-2026) & (M Units) Table 40. Global Veterinary Drug Sales Volume by Application (2027-2032) & (M Units) Table 41. Global Veterinary Drug Sales Volume Share by Application (2021-2026) Table 42. Global Veterinary Drug Sales Volume Share by Application (2027-2032) Table 43. Global Veterinary Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Veterinary Drug Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Veterinary Drug Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Veterinary Drug Sales Value Share by Application (2021-2026) Table 47. Global Veterinary Drug Sales Value Share by Application (2027-2032) Table 48. Global Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 49. Global Veterinary Drug Sales by Region (2021-2026) & (M Units) Table 50. Global Veterinary Drug Sales Market Share by Region (2021-2026) Table 51. Global Veterinary Drug Sales by Region (2027-2032) & (M Units) Table 52. Global Veterinary Drug Sales Market Share by Region (2027-2032) Table 53. Global Veterinary Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Veterinary Drug Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Veterinary Drug Sales Value Share by Region (2021-2026) Table 56. Global Veterinary Drug Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Veterinary Drug Sales Value Share by Region (2027-2032) Table 58. Global Veterinary Drug Market Average Price (USD/Unit) by Region (2021-2026) Table 59. Global Veterinary Drug Market Average Price (USD/Unit) by Region (2027-2032) Table 60. Global Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 61. Global Veterinary Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 63. Global Veterinary Drug Sales Market Share by Country (2021-2026) Table 64. Global Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 65. Global Veterinary Drug Sales Market Share by Country (2027-2032) Table 66. Global Veterinary Drug Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Veterinary Drug Sales Value Market Share by Country (2021-2026) Table 68. Global Veterinary Drug Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Veterinary Drug Sales Value Market Share by Country (2027-2032) Table 70. Zoetis Company Information Table 71. Zoetis Business Overview Table 72. Zoetis Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Zoetis Veterinary Drug Product Portfolio Table 74. Zoetis Recent Development Table 75. Elanco Company Information Table 76. Elanco Business Overview Table 77. Elanco Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Elanco Veterinary Drug Product Portfolio Table 79. Elanco Recent Development Table 80. Boehringer Ingelheim Company Information Table 81. Boehringer Ingelheim Business Overview Table 82. Boehringer Ingelheim Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Boehringer Ingelheim Veterinary Drug Product Portfolio Table 84. Boehringer Ingelheim Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Merck Veterinary Drug Product Portfolio Table 89. Merck Recent Development Table 90. Virbac Company Information Table 91. Virbac Business Overview Table 92. Virbac Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Virbac Veterinary Drug Product Portfolio Table 94. Virbac Recent Development Table 95. Ceva Company Information Table 96. Ceva Business Overview Table 97. Ceva Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Ceva Veterinary Drug Product Portfolio Table 99. Ceva Recent Development Table 100. Vetoquinol Company Information Table 101. Vetoquinol Business Overview Table 102. Vetoquinol Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Vetoquinol Veterinary Drug Product Portfolio Table 104. Vetoquinol Recent Development Table 105. Dechra Company Information Table 106. Dechra Business Overview Table 107. Dechra Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Dechra Veterinary Drug Product Portfolio Table 109. Dechra Recent Development Table 110. Norbrook Company Information Table 111. Norbrook Business Overview Table 112. Norbrook Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Norbrook Veterinary Drug Product Portfolio Table 114. Norbrook Recent Development Table 115. Phibro Company Information Table 116. Phibro Business Overview Table 117. Phibro Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Phibro Veterinary Drug Product Portfolio Table 119. Phibro Recent Development Table 120. Huvepharma Company Information Table 121. Huvepharma Business Overview Table 122. Huvepharma Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Huvepharma Veterinary Drug Product Portfolio Table 124. Huvepharma Recent Development Table 125. Hipra Company Information Table 126. Hipra Business Overview Table 127. Hipra Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Hipra Veterinary Drug Product Portfolio Table 129. Hipra Recent Development Table 130. Ouro Fino Saude Company Information Table 131. Ouro Fino Saude Business Overview Table 132. Ouro Fino Saude Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Ouro Fino Saude Veterinary Drug Product Portfolio Table 134. Ouro Fino Saude Recent Development Table 135. CAHIC Company Information Table 136. CAHIC Business Overview Table 137. CAHIC Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. CAHIC Veterinary Drug Product Portfolio Table 139. CAHIC Recent Development Table 140. Orion Company Information Table 141. Orion Business Overview Table 142. Orion Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 143. Orion Veterinary Drug Product Portfolio Table 144. Orion Recent Development Table 145. Ringpu Biology Company Information Table 146. Ringpu Biology Business Overview Table 147. Ringpu Biology Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 148. Ringpu Biology Veterinary Drug Product Portfolio Table 149. Ringpu Biology Recent Development Table 150. Nippon Zenyaku Kogyo Company Information Table 151. Nippon Zenyaku Kogyo Business Overview Table 152. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 153. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio Table 154. Nippon Zenyaku Kogyo Recent Development Table 155. Farmavet-Pasteur Company Information Table 156. Farmavet-Pasteur Business Overview Table 157. Farmavet-Pasteur Veterinary Drug Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 158. Farmavet-Pasteur Veterinary Drug Product Portfolio Table 159. Farmavet-Pasteur Recent Development Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Veterinary Drug Distributors List Table 163. Veterinary Drug Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Veterinary Drug Product Image Figure 2. Global Veterinary Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Drug Sales (2021-2032) & (M Units) Figure 5. Global Veterinary Drug Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Veterinary Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Anti-Infectives Image Figure 10. Anti-Inflammatory Image Figure 11. Parasiticides Image Figure 12. Analgesics Image Figure 13. Sedatives Image Figure 14. Others Image Figure 15. Global Veterinary Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 16. Global Veterinary Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Veterinary Drug Sales Volume Share by Type (2021-2032) Figure 18. Global Veterinary Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Veterinary Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Veterinary Drug Sales Value Share by Type (2021-2032) Figure 21. Pets Image Figure 22. Cattle Image Figure 23. Poultry Image Figure 24. Swine Image Figure 25. Others Image Figure 26. Global Veterinary Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 27. Global Veterinary Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Drug Sales Volume Share by Application (2021-2032) Figure 29. Global Veterinary Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Veterinary Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Veterinary Drug Sales Value Share by Application (2021-2032) Figure 32. Global Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 33. Global Veterinary Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Veterinary Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Veterinary Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 37. North America Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 43. South America Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Veterinary Drug Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Veterinary Drug Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others
Applications
  • Pets
  • Cattle
  • Poultry
  • Swine
  • Others
Companies covered
  • Zoetis
  • Elanco
  • Boehringer Ingelheim
  • Merck
  • Virbac
  • Ceva
  • Vetoquinol
  • Dechra
  • Norbrook
  • Phibro
  • Huvepharma
  • Hipra
  • Ouro Fino Saude
  • CAHIC
  • Orion
  • Ringpu Biology
  • Nippon Zenyaku Kogyo
  • Farmavet-Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Drug Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Drug Market Dynamics
  1. 2.1 Veterinary Drug Industry Trends
  2. 2.2 Veterinary Drug Industry Drivers
  3. 2.3 Veterinary Drug Industry Opportunities and Challenges
  4. 2.4 Veterinary Drug Industry Restraints
3 Veterinary Drug Market by Company
  1. 3.1 Global Veterinary Drug Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Drug Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Drug Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Drug Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Drug Company Product Type and Application
  8. 3.8 Global Veterinary Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Drug Market by Type
  1. 4.1 Veterinary Drug Type Introduction
  2. 4.1.1 Anti-Infectives
  3. 4.1.2 Anti-Inflammatory
  4. 4.1.3 Parasiticides
  5. 4.1.4 Analgesics
  6. 4.1.5 Sedatives
  7. 4.1.6 Others
  8. 4.2 Global Veterinary Drug Sales Volume by Type
  9. 4.2.1 Global Veterinary Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Veterinary Drug Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Veterinary Drug Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Veterinary Drug Sales Value by Type
  13. 4.3.1 Global Veterinary Drug Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Veterinary Drug Sales Value by Type (2021-2032)
  15. 4.3.3 Global Veterinary Drug Sales Value Share by Type (2021-2032)
5 Veterinary Drug Market by Application
  1. 5.1 Veterinary Drug Application Introduction
  2. 5.1.1 Pets
  3. 5.1.2 Cattle
  4. 5.1.3 Poultry
  5. 5.1.4 Swine
  6. 5.1.5 Others
  7. 5.2 Global Veterinary Drug Sales Volume by Application
  8. 5.2.1 Global Veterinary Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Veterinary Drug Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Veterinary Drug Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Veterinary Drug Sales Value by Application
  12. 5.3.1 Global Veterinary Drug Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Veterinary Drug Sales Value by Application (2021-2032)
  14. 5.3.3 Global Veterinary Drug Sales Value Share by Application (2021-2032)
6 Veterinary Drug Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Drug Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Drug Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Drug Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Drug Sales Value Share by Country, 2025 VS 2032
7 Veterinary Drug Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Drug Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary Drug Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Elanco
  8. 8.2.1 Elanco Company Information
  9. 8.2.2 Elanco Business Overview
  10. 8.2.3 Elanco Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Elanco Veterinary Drug Product Portfolio
  12. 8.2.5 Elanco Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Veterinary Drug Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Virbac
  26. 8.5.1 Virbac Company Information
  27. 8.5.2 Virbac Business Overview
  28. 8.5.3 Virbac Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Virbac Veterinary Drug Product Portfolio
  30. 8.5.5 Virbac Recent Developments
  31. 8.6 Ceva
  32. 8.6.1 Ceva Company Information
  33. 8.6.2 Ceva Business Overview
  34. 8.6.3 Ceva Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Veterinary Drug Product Portfolio
  36. 8.6.5 Ceva Recent Developments
  37. 8.7 Vetoquinol
  38. 8.7.1 Vetoquinol Company Information
  39. 8.7.2 Vetoquinol Business Overview
  40. 8.7.3 Vetoquinol Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Vetoquinol Veterinary Drug Product Portfolio
  42. 8.7.5 Vetoquinol Recent Developments
  43. 8.8 Dechra
  44. 8.8.1 Dechra Company Information
  45. 8.8.2 Dechra Business Overview
  46. 8.8.3 Dechra Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Dechra Veterinary Drug Product Portfolio
  48. 8.8.5 Dechra Recent Developments
  49. 8.9 Norbrook
  50. 8.9.1 Norbrook Company Information
  51. 8.9.2 Norbrook Business Overview
  52. 8.9.3 Norbrook Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Norbrook Veterinary Drug Product Portfolio
  54. 8.9.5 Norbrook Recent Developments
  55. 8.10 Phibro
  56. 8.10.1 Phibro Company Information
  57. 8.10.2 Phibro Business Overview
  58. 8.10.3 Phibro Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Phibro Veterinary Drug Product Portfolio
  60. 8.10.5 Phibro Recent Developments
  61. 8.11 Huvepharma
  62. 8.11.1 Huvepharma Company Information
  63. 8.11.2 Huvepharma Business Overview
  64. 8.11.3 Huvepharma Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Huvepharma Veterinary Drug Product Portfolio
  66. 8.11.5 Huvepharma Recent Developments
  67. 8.12 Hipra
  68. 8.12.1 Hipra Company Information
  69. 8.12.2 Hipra Business Overview
  70. 8.12.3 Hipra Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hipra Veterinary Drug Product Portfolio
  72. 8.12.5 Hipra Recent Developments
  73. 8.13 Ouro Fino Saude
  74. 8.13.1 Ouro Fino Saude Company Information
  75. 8.13.2 Ouro Fino Saude Business Overview
  76. 8.13.3 Ouro Fino Saude Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
  78. 8.13.5 Ouro Fino Saude Recent Developments
  79. 8.14 CAHIC
  80. 8.14.1 CAHIC Company Information
  81. 8.14.2 CAHIC Business Overview
  82. 8.14.3 CAHIC Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 CAHIC Veterinary Drug Product Portfolio
  84. 8.14.5 CAHIC Recent Developments
  85. 8.15 Orion
  86. 8.15.1 Orion Company Information
  87. 8.15.2 Orion Business Overview
  88. 8.15.3 Orion Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Orion Veterinary Drug Product Portfolio
  90. 8.15.5 Orion Recent Developments
  91. 8.16 Ringpu Biology
  92. 8.16.1 Ringpu Biology Company Information
  93. 8.16.2 Ringpu Biology Business Overview
  94. 8.16.3 Ringpu Biology Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Ringpu Biology Veterinary Drug Product Portfolio
  96. 8.16.5 Ringpu Biology Recent Developments
  97. 8.17 Nippon Zenyaku Kogyo
  98. 8.17.1 Nippon Zenyaku Kogyo Company Information
  99. 8.17.2 Nippon Zenyaku Kogyo Business Overview
  100. 8.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
  102. 8.17.5 Nippon Zenyaku Kogyo Recent Developments
  103. 8.18 Farmavet-Pasteur
  104. 8.18.1 Farmavet-Pasteur Company Information
  105. 8.18.2 Farmavet-Pasteur Business Overview
  106. 8.18.3 Farmavet-Pasteur Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
  108. 8.18.5 Farmavet-Pasteur Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Drug Value Chain Analysis
  2. 9.1.1 Veterinary Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Drug Sales Mode & Process
  6. 9.2 Veterinary Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Drug Distributors
  9. 9.2.3 Veterinary Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst